Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer
1998

Preoperative CEA and Colorectal Cancer Survival

Sample size: 277 publication Evidence: moderate

Author Information

Author(s): MAS Chapman, D Buckley, DB Henson, NC Armitage

Primary Institution: University Hospital, Queens Medical Centre, Nottingham, UK

Hypothesis

The study investigates the value of preoperative carcinoembryonic antigen (CEA) in predicting tumour factors and long-term survival in colorectal cancer patients.

Conclusion

A raised preoperative serum CEA is associated with advanced tumour stage and poor long-term survival, but is not a useful predictor of survival once tumour stage is known.

Supporting Evidence

  • Patients with an elevated CEA had a 5-year survival of 39%.
  • This increased to 57% if the CEA was normal.
  • The proportion of patients with a raised CEA increased with a more advanced tumour stage.
  • Once stage was controlled for, CEA was not a predictor of survival.

Takeaway

If a patient has high levels of a certain protein before surgery for colon cancer, it might mean their cancer is more advanced and they may not live as long, but knowing this doesn't help predict how long they will live once the cancer stage is known.

Methodology

The study measured preoperative serum CEA levels in 277 patients undergoing colorectal cancer surgery and followed them for a minimum of 5 years.

Limitations

The study does not account for the potential impact of adjuvant chemotherapy on survival outcomes.

Participant Demographics

Median age of participants was 67 years, with a range of 40-87 years.

Statistical Information

P-Value

0.001

Confidence Interval

95% confidence intervals 1.4-2.9

Statistical Significance

p<0.000001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication